Table 15 CVVH characteristics and cost impact simulations
From: French Intensive Care Society, International congress – Réanimation 2016
All (n = 74) Mean (SD) | Citrate (n = 31) Mean (SD) | No citrate (n = 43) Mean (SD) | p* | ||||
|---|---|---|---|---|---|---|---|
CVVH dose (ml/kg/h) | 36.4 (8.3) | 36.2 (9.2) | 36.5 (7.6) | 0.89 | |||
Hemofiltration rate (%) | 14.8 (3.7) | 16.5 (1.7) | 13.5 (4.3) | <0.0001 | |||
Mean effective duration (h) | 52.1 (60.7) | 53.8 (60.8) | 50.8 (61.3) | 0.16 | |||
Total cost (€) | 70,385.1 | 26,024.1 | 44,361.0 | – | |||
Simulated cost (€) | 64,658.8 | 25,052.5 | 39,606.3 | – | |||
Mean cost/24 h (€) | 590.9 (433.0) | p′ = 0.0005 | 535.2 (383.6) | p′ = 0.001 | 631.0 (465.6) | p′ = 0.001 | 0.33 |
Mean simulated cost/24 h (€) | 564.5 (396.2) | 525.3 (387.3) | 561.8 (406.3) | 0.69 | |||